📰 Abt News
Page 185 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 4, 2023
Nikulski Financial Inc. raised its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 17.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,654 shares of the healthcare product maker’s stock after acquiring an additional 1,135 shares during the quarter. Nikulski Financial […]
April 4, 2023
Boenning & Scattergood Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 58,347 shares of the healthcare product maker’s stock after selling 621 shares during the quarter. Abbott […]
April 4, 2023
Arcblock (ABT) traded 0% higher against the U.S. dollar during the 1 day period ending at 16:00 PM ET on April 4th. Arcblock has a total market capitalization of $12.84 million and $235,920.39 worth of Arcblock was traded on exchanges in the last 24 hours. During the last seven days, Arcblock has traded up 8.5% […]
April 4, 2023
Barry Investment Advisors LLC increased its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 5.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,557 shares of the healthcare product maker’s stock after purchasing an additional 122 shares during […]
April 3, 2023
Arcblock (ABT) traded up 0.2% against the dollar during the twenty-four hour period ending at 22:00 PM E.T. on April 2nd. Arcblock has a market cap of $12.92 million and approximately $221,426.84 worth of Arcblock was traded on exchanges in the last day. One Arcblock token can now be bought for about $0.13 or 0.00000472 […]
April 3, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its target price decreased by Bank of America from $125.00 to $115.00 in a report released on Thursday morning, The Fly reports. ABT has been the topic of several other reports. Morgan Stanley increased their target price on shares of Abbott Laboratories from $117.00 to $133.00 and gave […]
April 3, 2023
Arcblock (ABT) traded 1% lower against the U.S. dollar during the 24 hour period ending at 14:00 PM ET on April 3rd. Over the last week, Arcblock has traded up 9% against the U.S. dollar. Arcblock has a market capitalization of $12.85 million and approximately $238,770.17 worth of Arcblock was traded on exchanges in the […]
April 3, 2023
Tarbox Family Office Inc. grew its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 12.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 50,740 shares of the healthcare product maker’s stock after buying an additional 5,714 shares during the quarter. Abbott Laboratories comprises 1.2% of Tarbox Family Office Inc.’s portfolio, making the stock […]
April 3, 2023
Colton Groome Financial Advisors LLC lowered its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 28.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,965 shares of the healthcare product maker’s stock after selling 800 shares during the period. Colton Groome Financial Advisors LLC’s holdings in Abbott Laboratories were worth $216,000 at […]
April 3, 2023
SNS Financial Group LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 15,174 shares of the healthcare product maker’s stock after buying an additional 143 shares during the quarter. SNS Financial Group LLC’s holdings in Abbott Laboratories were […]